ANTITUMOR IMIDAZOTETRAZINES .25. CRYSTAL-STRUCTURE OF 8-CARBAMOYL-3-METHYLIMIDAZO[5,1-D]-1,2,3,5-TETRAZIN-4(3H)-ONE (TEMOZOLOMIDE) AND STRUCTURAL COMPARISONS WITH THE RELATED DRUGS MITOZOLOMIDE AND DTIC

被引:55
作者
LOWE, PR [1 ]
SANSOM, CE [1 ]
SCHWALBE, CH [1 ]
STEVENS, MFG [1 ]
CLARK, AS [1 ]
机构
[1] UNIV ASTON, INST PHARMACEUT SCI, BIRMINGHAM B4 7ET, W MIDLANDS, ENGLAND
关键词
D O I
10.1021/jm00096a013
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The antitumor imidazotetrazinone, temozolomide (5), C6H6N6O2, forms crystals with unit cell dimensions a = 17.332 (3), b = 7.351 (2), c = 13.247 (1), beta = 109.56 (1)-degrees and space group P2(1)/c. A doubly hydrogen-bonded dimer constitutes the asymmetric unit. One carboxamide group forms an additional intermolecular NH...O hydrogen bond; in both molecules the carboxamide group is coplanar with the heterocycle and its NH2 group interacts with the imidazole nitrogen atom N(7). Molecular orbital calculations show the carbonyl carbon C(4) to be the most electron deficient atom, with relatively weak N(3)-C(4) and C(4)-N(5) bonds confirming that temozolomide should ring-open at this position in solution. The energy barrier to carboxamide group rotation of approximately 20 kJ mol-1 should permit interconversion between rotamers. In temozolomide and the related drug mitozolomide (4), N(7) is more negatively charged than N(1), which favors the formation Of hydrogen bonds to the former atom in spite of their poor geometry. The relevance of these structural features to the action of temozolomide as a major-groove-directed prodrug of the alkylating agent MTIC (3) is discussed.
引用
收藏
页码:3377 / 3382
页数:6
相关论文
共 30 条
[1]   ANTITUMOR IMIDAZOTETRAZINES .12. REACTIONS OF MITOZOLOMIDE AND ITS 3-ALKYL CONGENERS WITH OXYGEN, NITROGEN, HALOGEN, AND CARBON NUCLEOPHILES [J].
BAIG, GU ;
STEVENS, MFG .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 1987, (03) :665-670
[2]   PYRAZOLE DERIVATIVES .5. SYNTHESIS AND ANTINEOPLASTIC ACTIVITY OF 3-(2-CHLOROETHYL)-3,4-DIHYDRO-4-OXOPYRAZOLO[5,1-D]-1,2,3,5-TETRAZINE-8-CARBOXAMIDE AND RELATED-COMPOUNDS [J].
CHENG, CC ;
ELSLAGER, EF ;
WERBEL, LM ;
PRIEBE, SR ;
LEOPOLD, WR .
JOURNAL OF MEDICINAL CHEMISTRY, 1986, 29 (08) :1544-1547
[3]  
Clark A. M., UNPUB
[4]  
CLARK AS, 1990, ANTI-CANCER DRUG DES, V5, P63
[5]   INTEGRATION OF CHEMOTHERAPY INTO COMBINED MODALITY TREATMENT OF SOLID TUMORS .3. GASTRIC CANCER [J].
COMIS, RL ;
CARTER, SK .
CANCER TREATMENT REVIEWS, 1974, 1 (03) :221-238
[6]  
DAVIES K, 1988, CHEM X
[7]  
DOLL R, 1990, EUR J CANCER, V26, P500
[8]   CRYSTAL-STRUCTURE OF ANTITUMOR AGENT 5-(3,3-DIMETHYL-1-TRIAZENO)IMIDAZOLE-4-CARBOXAMIDE MONOHYDRATE HYDROCHLORIDE (NSC-45388) [J].
EDWARDS, SL ;
SHERFINSKI, JS ;
MARSH, RE .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1974, 96 (08) :2593-2597
[9]  
FODSTAD O, 1985, CANCER RES, V45, P1778
[10]   CRYSTAL-STRUCTURE OF THE ANTI-TUMOR AGENT 5-(3,3-DIMETHYL-1-TRIAZENYL)IMIDAZOLE-4-CARBOXAMIDE (NSC-45388) [J].
FREEMAN, HC ;
HUTCHINSON, ND .
ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE, 1979, 35 (SEP) :2051-2054